Assignee
A2A PHARMACEUTICALS INC
US·2 granted patents·3 pending applications·2 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0168US11986475B1Compositions and methods for treating cancerA2A PHARMACEUTICALS INC·Filed 2023·Granted May 21, 2024·0 cites·28 claims
- 0266US11622966B2Highly potent TACC3 inhibitor as a novel anticancer drug candidateA2A PHARMACEUTICALS INC·Filed 2019·Granted Apr 11, 2023·2 cites·18 claims
- 0360US2025206728A1Compositions and methods for treating cancerA2A PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0446US2024374590A1Compositions and methods for treating cancerA2A PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0539US2023027854A1Isoxazole derivatives targeting tacc3 as anticancer agentsA2A PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →